Format

Send to

Choose Destination
Bioorg Med Chem. 2008 May 1;16(9):4759-800. doi: 10.1016/j.bmc.2008.02.091. Epub 2008 Mar 4.

Recent advances in selective alpha1-adrenoreceptor antagonists as antihypertensive agents.

Author information

1
Sinhgad College of Pharmacy, Pune 411041, India. kishor.s.jain@gmail.com

Abstract

Hypertension is one of the most serious health problems of the modern world with a continuous rise in the number of patients. Selective alpha(1)-adrenoreceptor antagonists though have many advantages and uses in the management of arterial hypertension, their lack of specificity at the level of alpha(1)-adr subtypes leads to multiple side effects. Existence of multiple alpha(1)-adr subtypes holds great promise for the discovery and development of more specific and selective drug molecules, targeting only one alpha(1)-adr subtype at a time and thus relative freedom from side effects. Herein, the research done on the discovery and evaluation of a variety of chemically diverse structures as selective antagonists of alpha(1)-adr and alpha(1)-adr subtypes in recent years has been reviewed.

PMID:
18378462
DOI:
10.1016/j.bmc.2008.02.091
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center